New Products/Product News
| DJO Incorporated, a global provider of medical devices that deliver solutions for musculoskeletal health, vascular health, and pain management, announced that its Chattanooga business has received 510(k) clearance from the US FDA to market and sell the Intelect® SWD Shortwave Diathermy device in the United States. Plans are under way to bring the unit to market in spring 2009.
Chattanooga’s new Intelect SWD innovations include a touch screen interface and onboard software that allows therapists to customize their patient’s therapy. DJO notes that the Shortwave Diathermy unit is the only domestic shortwave product to operate via a touch screen interface. The unit is very simple to use. Therapists can begin treatment in as few as 2 touches to the home screen.
Shortwave diathermy is a clinical treatment modality that provides a superior form of deep-tissue heating. Indications for use include: pain relief, reduction of muscle spasm, decreasing joint stiffness, contractures, increased blood flow, chronic inflammatory conditions, bursitis, tenosynovitis, synovitis, and chronic inflammatory pelvic disease.
For more information, contact
DJO, LLC.
|
Injectable Paste and Moldable Putty
| ETEX Corporation announced FDA 510k clearance of 1-cm3 and 2.5-cm3 sizes of Beta-bsm™ Injectable Paste and Gamma-bsm™ Moldable Putty to complement the existing 5-cm3and 10-cm3 sizes. Both products are bone-substitute mate-rials based on ETEX’s proprietary nanocrystalline calcium phosphate technology.
Beta-bsm™ and Gamma-bsm™ set hard to provide an optimal osteoconductive scaffold that mimics the nanocrystalline structure of human bone. Smaller sizes were developed in direct response to the needs of the small-bone market. Both hand and foot/ankle surgeons requested user-friendly moldable and injectable materials that set fast, are drillable, provide high compressive strength, and remodel into bone over time.
Beta-bsm™ Injectable Paste and Gamma-bsm™ Moldable Putty are intended for use in filling bone voids or defects of the skeletal system (including extremities, pelvis, and spine) that are not intrinsic to the stability of the bone structure.
For more information, contact
ETEX
|
Injectable Bone Graft Replacement
DePuy Spine, Inc., announced the launch of HEALOS® Fx Injectable Bone Graft Replacement ( |